Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3CPC

Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor

Summary for 3CPC
Entry DOI10.2210/pdb3cpc/pdb
Related3CP9 3CPB
DescriptorVascular endothelial growth factor receptor 2, 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one (3 entities in total)
Functional Keywordsreceptor tyrosine kinase, angiogenesis, atp-binding, developmental protein, differentiation, glycoprotein, host-virus interaction, immunoglobulin domain, membrane, nucleotide-binding, phosphoprotein, transferase, transmembrane, tyrosine-protein kinase
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight73361.90
Authors
Whittington, D.A.,Long, A.M.,Rose, P.,Gu, Y.,Zhao, H. (deposition date: 2008-03-31, release date: 2008-06-17, Last modification date: 2024-02-21)
Primary citationHu, E.,Tasker, A.,White, R.D.,Kunz, R.K.,Human, J.,Chen, N.,Burli, R.,Hungate, R.,Novak, P.,Itano, A.,Zhang, X.,Yu, V.,Nguyen, Y.,Tudor, Y.,Plant, M.,Flynn, S.,Xu, Y.,Meagher, K.L.,Whittington, D.A.,Ng, G.Y.
Discovery of Aryl Aminoquinazoline Pyridones as Potent, Selective, and Orally Efficacious Inhibitors of Receptor Tyrosine Kinase c-Kit.
J.Med.Chem., 51:3065-3068, 2008
Cited by
PubMed: 18447379
DOI: 10.1021/jm800188g
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

218500

PDB entries from 2024-04-17

PDB statisticsPDBj update infoContact PDBjnumon